PROMEDIOR
Promedior is a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of inflammatory and fibrotic diseases Promedior has developed a novel drug discovery platform to regulate the monocyte-derived cell populations that play key roles in fibrotic, inflammatory and autoimmune diseases. By specifically targeting these cells at the site of injury, Promedior is able to treat the source of aberrant immune system responses, promote tissue healing and resolution, an... d greatly reduce the risk of systemic side effects inherent in current therapeutic approaches. Promedior is developing drugs to address the most severe and difficult-to-treat fibrotic and inflammatory conditions of the eye, lung and kidney such as glaucoma, age-related macular degeneration, diabetic retinopathy and dry eye disease; pulmonary fibrosis, scleroderma and COPD; and acute and chronic nephropathy.
PROMEDIOR
Industry:
Biopharma Biotechnology Health Care Therapeutics
Founded:
2006-01-01
Address:
Lexington, Massachusetts, United States
Country:
United States
Website Url:
http://www.roche.com
Total Employee:
51+
Status:
Active
Contact:
781-538-4200
Email Addresses:
[email protected]
Total Funding:
63 M USD
Technology used in webpage:
Viewport Meta SPF Mobile Non Scaleable Content IPv6 Google Maps Microsoft Mimecast Akamai DNS
Similar Organizations
Adamis Pharmaceuticals
Adamis Pharmaceuticals is a biopharmaceutical company developing therapeutics for respiratory diseases and cancer.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
ReVision Therapeutics
ReVision Therapeutics, a biopharmaceutical company, develops drugs for the treatment of age-related macular degeneration diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sofinnova Investments
Sofinnova Investments investment in Venture Round - Promedior
Shire
Shire investment in Series D - Promedior
HealthCare Ventures
HealthCare Ventures investment in Series D - Promedior
Forbion Capital Partners
Forbion Capital Partners investment in Series D - Promedior
Fibrotic Ventures
Fibrotic Ventures investment in Series D - Promedior
Polaris Partners
Polaris Partners investment in Series D - Promedior
Morgenthaler Ventures
Morgenthaler Ventures investment in Series D - Promedior
Easton Capital
Easton Capital investment in Series D - Promedior
Easton Capital
Easton Capital investment in Series D - Promedior
Fibrotic Ventures
Fibrotic Ventures investment in Series D - Promedior
Official Site Inspections
http://www.roche.com Semrush global rank: 4.41 M Semrush visits lastest month: 959
- Host name: promedior.com
- IP address: 198.21.19.135
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
